tars (Santa Cruz Biotechnology)
90
Structured Review
Santa Cruz Biotechnology
tars

Tars, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/immunohistochemistry+microarray+based+expression+data/ThrRS+Antibody/pmc04155084-65-21-24
Average 90 stars, based on 2 article reviews

Tars, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/immunohistochemistry+microarray+based+expression+data/ThrRS+Antibody/pmc04155084-65-21-24
Average 90 stars, based on 2 article reviews
tars - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer"
Article Title: Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer
Journal: BMC Cancer
doi: 10.1186/1471-2407-14-620
Figure Legend Snippet: TARS mRNA levels are increased in ovarian cancer and reduced by neo - adjuvant chemotherapy. Data were obtained from GEO dataset GDS 2785. The study analyzed mRNA by GeneChip microarray in ovarian tissue from 10 patients with benign conditions, 9 patients with untreated adenocarcinoma, and 24 patients with adenocarcinoma treated with carboplatin/taxol prior to surgery (+Chemo) . Shown are expression profile comparisons for A , TARS, B , VEGF, C , SARS and D , YARS. Differences between groups was significant for TARS and VEGF as determined by ANOVA Kruskal Wallis analysis, *p < 0.0001 compared with benign, #p < 0.001 compared with carcinoma.
Techniques Used: Adjuvant, Microarray, Expressing
Figure Legend Snippet: TARS expression increases with stage of ovarian cancer. A . Tissues were stained for TARS by immunohistochemistry and counter-stained with Mayers’ hematoxylin. Images were scored blindly by 2 independent investigators and tumor identification was later confirmed by a pathologist (SLM). Shown are 10x images from (1) normal ovary and examples of TARS score increasing with extent of disease (2–4), Bar = 100 μm. B . Graph representing average scores where high stage is ≥ stage 3; statistical significance determined by one-way ANOVA. For more detailed statistics, see Table for Pearson’s Correlations. C . Shown is a graph of individual patient TARS tumor scores grouped according to FIGO stage of disease (i.e. Stage 3.75 = FIGO 3C).
Techniques Used: Expressing, Staining, Immunohistochemistry
Figure Legend Snippet: Pearson Correlation Matrix for TARS expression in ovarian cancer patient samples
Techniques Used: Expressing
Figure Legend Snippet: TARS is secreted by SK - OV - 3 ovarian cancer cells. (A) SK-OV-3 cells were treated with TNF-α (50 ng/ml) or exposed to 2% O 2 for 24 h where indicated. Media was concentrated 20-fold to accommodate 25% onto the gel and compared to 5% of the cell lysate. Shown is a representative Western blot probed for TARS and β-tubulin, n = 4. (B) Cells were treated as in (A) . After 24 h the level of TARS in the supernatant was determined by ELISA, *p < 0.05, n = 3. Cell membrane integrity was confirmed using the lactate dehydrogenase assay CytoTox-ONE™ and by lack of β-tubulin in media samples. (C) Relative mRNA levels for TARS, VEGF and IL-1β were determined by RT-qPCR following treatment as in (A) ; *p < 0.001, **p < 0.0001, n = 4.
Techniques Used: Western Blot, Enzyme-linked Immunosorbent Assay, Membrane, Lactate Dehydrogenase Assay, Quantitative RT-PCR
Figure Legend Snippet: Correlation of TARS levels detected in serum with TARS expression in ovarian cancer. Graphs represent scatter dot plots (mean ± SD) of patient data for TARS serum levels against (A) Stage of cancer and (B) TARS tumor tissue score. The correlation (r-value) and p-values were calculated by a Pearson correlation matrix (see Table ).
Techniques Used: Expressing
Figure Legend Snippet: Hazard ratios for the association of TARS with mortality using univariate Cox proportional hazard models
Techniques Used:
Figure Legend Snippet: Multivariate Cox proportional hazard model for TARS tumor score
Techniques Used:
Related Articles
other:Article Title: Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration Article Snippet: Anti-MUC1 (cat# ab109185) was purchased from Abcam (Cambridge, UK), anti-MUC1 (cat# sc-7313), anti-ThrRS (cat# sc-166146), anti-c-Myc (cat# sc-40), and Article Title: Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration. Article Snippet: Anti-MUC1 (cat# ab109185) was purchased from Abcam (Cambridge, UK), anti-MUC1 (cat# sc-7313), anti-ThrRS (cat# sc-166146), anti-cMyc (cat# sc-40), and SDS Page:Article Title: Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer. Article Snippet: .. Cell lysates (5%) and corresponding concentrated cell media (25%) were separated by SDS-PAGE and analyzed by Western blot for presence of Article Title: Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer Article Snippet: .. Cell lysates (5%) and corresponding concentrated cell media (25%) were separated by SDS-PAGE and analyzed by Western blot for presence of Western Blot:Article Title: Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer. Article Snippet: .. Cell lysates (5%) and corresponding concentrated cell media (25%) were separated by SDS-PAGE and analyzed by Western blot for presence of Article Title: Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer Article Snippet: .. Cell lysates (5%) and corresponding concentrated cell media (25%) were separated by SDS-PAGE and analyzed by Western blot for presence of Control:Article Title: Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer. Article Snippet: .. Cell lysates (5%) and corresponding concentrated cell media (25%) were separated by SDS-PAGE and analyzed by Western blot for presence of Article Title: Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer Article Snippet: .. Cell lysates (5%) and corresponding concentrated cell media (25%) were separated by SDS-PAGE and analyzed by Western blot for presence of Lysis:Article Title: Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer. Article Snippet: .. Cell lysates (5%) and corresponding concentrated cell media (25%) were separated by SDS-PAGE and analyzed by Western blot for presence of Article Title: Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer Article Snippet: .. Cell lysates (5%) and corresponding concentrated cell media (25%) were separated by SDS-PAGE and analyzed by Western blot for presence of |